Schorno Dean L

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
7 29% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -14%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Schorno Dean L's trades of Rigel Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-06 2025-02-05
S Sale
71,670 +18.5%
149.26
US$2,672,703 		71,670 +18.5% 149.26 US$2,672,703
2025-02-05 2025-02-05
PrS Proposed sale
95,902
210.78
US$1,168,032 		95,902 210.78 US$1,168,032
2025-02-06 2025-02-04
S Sale
49,026 +21.0%
152.21
US$3,580,139 		49,026 +21.0% 152.21 US$3,580,139
2025-02-04 2025-02-04
PrS Proposed sale
2,036
20.92
US$42,596 		2,036 20.92 US$42,596
2024-02-06 2024-02-05
S Sale
7,027 -1.7%
1.14
US$8,011 		7,027 -1.7% 1.14 US$8,011
2024-02-06 2024-02-02
S Sale
5,601 -1.3%
1.13
US$6,327 		5,601 -1.3% 1.13 US$6,327
2023-02-06 2023-02-02
S Sale
5,389 -2.7%
1.66
US$8,946 		5,389 -2.7% 1.66 US$8,946
2019-05-23 2019-05-22
B Purchase
3,274 +7.0%
2.13
US$6,971 		3,274 +7.0% 2.13 US$6,971
2019-05-23 2019-05-22
B Purchase
46,726 +inf%
2.13
US$99,573 		46,726 +inf% 2.13 US$99,573